SE500494C2 - Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein och aspartam - Google Patents

Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein och aspartam

Info

Publication number
SE500494C2
SE500494C2 SE8702940A SE8702940A SE500494C2 SE 500494 C2 SE500494 C2 SE 500494C2 SE 8702940 A SE8702940 A SE 8702940A SE 8702940 A SE8702940 A SE 8702940A SE 500494 C2 SE500494 C2 SE 500494C2
Authority
SE
Sweden
Prior art keywords
weight
aspartame
pharmaceutical composition
composition according
citric acid
Prior art date
Application number
SE8702940A
Other languages
English (en)
Swedish (sv)
Other versions
SE8702940D0 (sv
SE8702940L (sv
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Original Assignee
Inpharzam Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam Int Sa filed Critical Inpharzam Int Sa
Publication of SE8702940D0 publication Critical patent/SE8702940D0/xx
Publication of SE8702940L publication Critical patent/SE8702940L/
Publication of SE500494C2 publication Critical patent/SE500494C2/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8702940A 1986-07-24 1987-07-23 Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein och aspartam SE500494C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2975/86A CH667590A5 (it) 1986-07-24 1986-07-24 Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .

Publications (3)

Publication Number Publication Date
SE8702940D0 SE8702940D0 (sv) 1987-07-23
SE8702940L SE8702940L (sv) 1988-01-25
SE500494C2 true SE500494C2 (sv) 1994-07-04

Family

ID=4245841

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702940A SE500494C2 (sv) 1986-07-24 1987-07-23 Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein och aspartam

Country Status (8)

Country Link
BE (1) BE1000355A3 (it)
CH (1) CH667590A5 (it)
DE (1) DE3723735A1 (it)
FR (1) FR2601876B1 (it)
GB (1) GB2192790B (it)
IT (1) IT1222104B (it)
NL (1) NL194067C (it)
SE (1) SE500494C2 (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung
SE462779B (sv) * 1988-10-10 1990-09-03 Lejus Medical Ab Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat
DE3909049A1 (de) * 1989-03-18 1990-09-20 Arthur Boskamp Praeparat und dessen verwendung
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
DE69209335T2 (de) * 1991-01-26 1996-08-29 Senju Pharma Co Mittel zur Zersetzung von Gallensteinen
DE4103360A1 (de) * 1991-02-05 1992-08-06 Koehler Peter Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
DE4406261C2 (de) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
DE19509856C2 (de) * 1995-03-17 1997-09-11 Schwabe Willmar Gmbh & Co Verwendung einer Brausezusammensetzung mit Ginkgo-Biloba Trockenextrakt zur Behandlung peripherer und cerebraler Durchblutungsstörungen
EP1115842A4 (en) 1998-09-25 2002-08-21 Glycox Corp Ltd DETERMINATION OF FRUCTOSAMINE OXIDASE: METHODS AND SUBSTANCES
CN1324234A (zh) 1998-09-25 2001-11-28 格利科克斯有限公司 果糖胺氧化酶,拮抗剂和抑制剂
WO2003077901A1 (en) 2002-03-08 2003-09-25 Protemix Corporation Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
JP2006503014A (ja) 2002-08-20 2006-01-26 プロテミックス コーポレイション リミティド 剤形及び関連する治療法
ES2449066T3 (es) 2004-07-19 2014-03-18 Philera New Zealand Limited Síntesis de trietilentetraminas
TR200900881A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
IT1399492B1 (it) 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN102233139B (zh) * 2010-04-21 2012-09-05 重庆健能医药开发有限公司 一种乙酰半胱氨酸泡腾片及其制备方法和应用
EP2571499A1 (en) * 2010-05-18 2013-03-27 Mahmut Bilgic Pharmaceutical composition comprising n- acetylcysteine and a xanthine
CN101947211A (zh) * 2010-08-28 2011-01-19 浙江金华康恩贝生物制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法
TR201104738A2 (tr) * 2011-05-16 2012-12-21 Bi̇lgi̇ç Mahmut N-Asetilsistein içeren farmasötik kombinasyon.
US8747894B2 (en) * 2012-05-08 2014-06-10 Alpex Pharma S.A. Effervescent compositions containing N-acetylcysteine
EP2905020A1 (en) 2014-02-05 2015-08-12 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations comprising ibuprofen and N-acetylcystein
CN113559078A (zh) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 一种乙酰半胱氨酸泡腾片的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470M (fr) * 1962-03-13 1964-04-20 Mead Johnson & Co Composition thérapeutique.
ZA723683B (en) * 1971-07-12 1973-06-27 Hoffmann La Roche Improved effervescent preparations
DE3317558A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Orales antischnarchmittel
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
DE3514995A1 (de) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut

Also Published As

Publication number Publication date
SE8702940D0 (sv) 1987-07-23
NL194067B (nl) 2001-02-01
FR2601876A1 (fr) 1988-01-29
DE3723735A1 (de) 1988-02-04
SE8702940L (sv) 1988-01-25
NL194067C (nl) 2001-06-05
BE1000355A3 (fr) 1988-11-08
CH667590A5 (it) 1988-10-31
IT8721411A0 (it) 1987-07-23
GB2192790A (en) 1988-01-27
IT1222104B (it) 1990-08-31
FR2601876B1 (fr) 1989-10-13
DE3723735C2 (it) 1992-05-21
GB8717582D0 (en) 1987-09-03
GB2192790B (en) 1990-01-31
NL8701743A (nl) 1988-02-16

Similar Documents

Publication Publication Date Title
SE500494C2 (sv) Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein och aspartam
SE500493C2 (sv) Farmaceutisk, vattenlöslig komposition, innehållande N-acetyl-cystein, aspartam och sorbitol
US4806358A (en) Therapeutic compositions
RU2417034C2 (ru) Упакованные твердые концентрированные изделия для приготовления бульона, супа, соуса, подливки или заправки или для использования в качестве приправы, способ их изготовления и применение
SE502285C2 (sv) Brusande farmaceutisk komposition innehållande ranitidin, samt förfarande för dess framställning
BRPI0719623A2 (pt) '' processos para produzir um concentrado na forma de partículas para preparar caldo, sopas, molhos, caldos de carne ou para uso como um tempero, para preparar um caldo ou concentrado de tempero na forma de um cubo ou tablete, concentrados na forma de partículas para preparar caldo, sopas, molhos, caldos de carne ou para uso como tempero e uso do concentrado''
JPS5645159A (en) Preparation of foamable chewing gum
ES2632416T3 (es) Proceso para comprimido de consomé
JPS6061517A (ja) 圧縮成形錠剤
JP2009518029A (ja) フレーバーカプセルを含有するインスタント食品
JP6702494B2 (ja) 固形物
US4113865A (en) Fruit juice-sugar granules
JPS6192530A (ja) 健康飲料
JP4865905B1 (ja) 消臭組成物
JP4641073B1 (ja) 消臭組成物
JP4722077B2 (ja) 薬膳うどんおよび薬膳うどんセット
JP2019201630A (ja) 固形物
JP3983011B2 (ja) 魚節削りの製造方法
AU6391294A (en) Palatable low salt substitutes
JPH04152868A (ja) 酒粕の粉末品または顆粒品の製法および酒粕の粉末品または顆粒品を用いた加工食品
JP2002255793A (ja) 粒状製剤
KR20040019433A (ko) 효모 폐박을 활용한 조미캡슐을 함유하는 면 및 이의제조방법
EP0058584A1 (fr) Procédé de fabrication d'une poudre stable contenant un produit actif très hygroscopique
JPH04299957A (ja) 風味および保存性の改善された調味料
JP2007044026A (ja) 粉末状梅肉エキス組成物

Legal Events

Date Code Title Description
NUG Patent has lapsed